The Hemophilia Foundation of Oregon enhances the quality of life for individuals with bleeding disorders and their families through advocacy, assistance, outreach, education and research support.

RSS RSS Newsfeed

  • Baxter Reports Gene Therapy Program Updates February 20, 2015
    Progress made by Baxter during clinical trial assessing the safety and optimal dosing level of BAX 335, an investigational factor IX (FIX) gene therapy. Read more about Baxter Reports Gene Therapy Program Updates Log in to post comments
  • Collaborating in Care Educational Modules Available Now February 18, 2015
    NHF is excited to partner with chapters to deliver six Collaborating in Care educational modules, some of which are now available. Read more about Collaborating in Care Educational Modules Available Now